Orthopedics

ICYMI: Funding Up for Stem Cell Companies Despite Lack of Evidence

ICYMI: Funding Up for Stem Cell Companies Despite Lack of Evidence

The stem cell therapies market is booming, thanks to ongoing unmet clinical needs, demographics, marketing, and advances in technology, but medical professionals are grappling with lack of evidence for most applications. Senior writer Wendy Diller explored stem cells’ use in orthopedics in our June 27 issue, and noted the exponential growth of financing for companies in the field.